Health Catalyst, Inc.
HCAT
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $124.9M
$1.69
▼ -1.17%
P/E
—
Mkt Cap
$124.9M
52-Wk Range
$0.96–$3.62
52-Week Range
$0.96 - $3.62
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 50.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Purpose-built healthcare data platform with deep clinical and operational expertise
- Integrated AI and machine learning capabilities that enhance analytics accuracy and actionability
- National data ecosystem providing benchmarking, collaboration, and thought leadership advantages
- Comprehensive solution suite addressing multiple healthcare pain points across the care continuum
- Established customer base with high switching costs and expanding use cases
Bear Case
1 risk
- Above-average volatility (beta 1.5).
Growth
Revenue decline expected
Increasing healthcare industry demand for data-driven decision making and digital transformation
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Stable
-3.4% over 3m
Quality
Strong
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying HCAT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
AUG 6, 2026
Reported EPS of $0.04 vs $0.03 consensus (+33.9% surprise). Revenue of $70.5M vs $69.1M expected (+2.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+33.9%
Revenue trend · last 8Q
—
+6%
+6%
+6%
-0%
-6%
-11%
-13%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$76.4M
$79.6M
$79.4M
$80.7M
$76.3M
$74.7M
$70.8M
$70.5M
Margins · last 8Q
Gross
66.2%
Operating
-51.8%
Profit
-57.5%
Wall Street consensus
3 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
—
Latest: Citi · Jul 23, 2026
vs Industry
How HCAT stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related